Print Page   |   Sign In   |   Register
Blog Home All Blogs
Search all posts for:   


View all (131) posts »

Stock Market Manager Weekly Update: December 26th, 2018

Posted By Administration, Wednesday, December 26, 2018

SMM Logo





Weekly Update: December 26th, 2018








Latest Happenings

Santa has come and gone and aside from all the good food and times with friends and family, he sure didn’t leave much under the tree for investors. Let’s hope things cheer up a little and here is wishing everyone a healthy and prosperous New Year!











From Bloomberg 12-26

With Trump Preaching Buy the Dip, Stocks Look Cheapest in Years

(Bloomberg) -- The flip side of what’s been the third-worst month for American stocks in the postwar era is that prices are a whole lot cheaper than they were before the rout.

While it may take a strong stomach to nibble at U.S. equities, they do offer the most attractive valuations since 2013, measured by the price-to-earnings ratio for the S&P 500 Index in data compiled by Bloomberg. At little more than 13 times the coming year’s estimated earnings, American stocks are also looking less of an outlier versus other advanced markets than earlier this year.

Read Complete Article

This has a been a great year for Stock Market Manager adding several new clients and increasing our distribution substantially through social Media and our quote media distribution agreement.. A lot more in the works for 2019 and we are well down the road to claiming a top industry spot as a premier distribution Network for Microcap research and news.

Feature Article

This week we have a great-very timely feature article on interest rates and the Bond Market from our friend Mark Sheik at Falcon Research

Powell - Jousting at Windmills to Find Neutral

  • Goldilocks economy gone after 9 rate hikes
  • Recession from flattening yield curve unlikely in coming year
  • Quantitative easing still effecting monetary policy
  • Self-correcting mechanisms help market find footing

The Federal Reserve seems to be in a quest to take the federal funds rate to neutral.  In fact since October 3rd when Federal Reserve chairman Jerome Powell said in an interview with Judy Woodruff that  “the central bank has a ways to go yet before it gets interest rates to where they are neither restrictive nor accommodative” the stock market has been in a tailspin and has corrected over 10% and over 13% for the tech weighted NASDAQ.  If you ask any Fed Governor the question what rate is neutral each one with start the answer with the qualifier “it depends.”  This article is going to explore what the fed means by neutral and what could be in store for the market should we actually get to neutral.    

What is Neutral? The Goldilocks Economy

Read Complete Article


Canbiola, Inc. (OTCQB: CANB)
Press Release 12-24-18

Canbiola, Inc. Expects Strong Revenue Growth from Q3 to Q4 2018 as President Trump Signs Farm Bill Legalizing Hemp CBD Nationwide

HICKSVILLE, NY, Dec. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Based upon a strong product demand, Canbiola (OTCQB: CANB) is on the path toward significant revenue growth. The Company has made significant investment in development of its nationwide distribution infrastructure through Its doctor and medical office network and expects this forward movement to continue.  This trend is even potentially more impactful with President Trump signing of the 2018 Farm Bill.   The 2018 Farm Bill removed CBD derived hemp from the Schedule 1 drug list and makes hemp CBD Federally legal for use, interstate transporting, and export.   Hemp based CBD with under .3% THC (the psychoactive ingredient in marijuana) has proven to be medically beneficial in a regimen of wellness and pain relief programs. 

“We believe we are in the right place at the right time with our public company offering a variety of CBD products under our proprietary formulation from the laboratory and production facility in Washington State,” states Canbiola’s CEO, Marco Alfonsi. “We have previously made several announcements regarding our growing number of doctors on our Medical Advisory board as well as our Corporate Advisory Board and with their guidance and some specialty production equipment in the WA facility, we expect to announce numerous new product opportunities.”  

According to a new article from Rolling Stone, The CBD market is expected to grow to $22 billion by 2022, see

From the Rolling Stone article: “CBD, a non-psychoactive cannabinoid found in cannabis, has had a surge in popularity over the past couple of years. Unlike THC, the chemical compound that gives weed its signature effect, CBD has been shown to help with everything from PTSD and anxiety to MS and epilepsy — without getting you high.”

Mr. Alfonsi concludes, “2019 is positioned to be a banner year for Canbiola as we have many new efforts underway and believe these efforts and investments will bear fruit. Canbiola’s entire product offering is 100% Federally legal.”

The Canbiola  family wishes everyone a happy holiday and a healthy and safe New Year.

About Canbiola, Inc.:

Canbiola, Inc. is a public company trading under symbol CANB.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at

Canbiola Investor Relations
Phone: (516) 595-9544
Follow us on Twitter and Facebook



Echelon Wealth Partners
Research Update 11-11-18
Antibe Therapeutics (TSXV-ATE)
Speculative Buy Target Price $1.40

Event: Ontario-based drug developer Antibe Therapeutics reported FQ219 financial data for the Sept-end quarter that met our expectations on most income statement metrics and on development timelines for flagship hydrogen sulfide-releasing naproxen analog ATB-346, as we will describe below. Bottom line:We are maintaining our Speculative BUY rating and $1.40 PT on ATE, with our valuation still based on NPV (40% discount rate) and multiples of our F2025 adjusted EBITDA/EPS forecasts ($165.6M/$0.41, respectively), with both profitability metrics driven by our expectations that ATB-346 can perform well in future Phase III knee osteoarthritis pain studies and that pending performance in the soon-to-commence 200-250-patient Phase II knee osteoarthritis will be sufficiently positive on key efficacy measures (WOMAC-based pain relief with simultaneous reduction in incidence/severity of gastroduodenal ulcers) to justify advancing into future pivotal studies and to support FDA approval/launch and “partnerability”. At current levels, our PT corresponds to a one-year return of 418%.

Read Complete Report

*Echelon is a leading independent, Canadian-owned and operated wealth management and capital markets firm. While SMM has no relationship with Echelon and is not being compensated for distribution of these research reports, Owners of SMM are significant shareholders in Antibe Holding which in turn has a significant interest in Antibe Therapeutics, Inc.

Trickle Research
Earnings Update 12-3-18
Summit Wireless Technologies, Inc. (WISA)
12-24 Month Target Price $9.25

There is not a great deal to update here since we just initiated the coverage near the end of this reporting period. As we noted in the initial coverage, we are not expecting much from the numbers for the second half, which of curse includes this reporting period and the one we are currently in. For what it is worth, the numbers were largely in lie. SG&A was a bit higher than we anticipated, but given the IPO in the quarter, as well as several other restructuring items (debt conversions etc.), we suspect that line item was particularly extraordinary.

Click Here for Report


Trickle Research Earnings Update 11-28-18
Social Reality, Inc. (SRAX)
12-24 Month Target Price $8.50

SRAX reported their 3QF18 results the other day, but with the holiday stuck between here and there, we are just catching up. Frankly there were no surprises of note. Recall, in some of our prior writings, we noted that the SRAXmd sale would “muddy” the Q3 numbers with extraordinary items. As it turned out, the numbers included about 37 days of SRAXmd contributions, which added to the extraordinariness. O

Click Here for Report

Trickle Research Earnings Update 11-13-18
Command Center, Inc. (CCNI)
12-24 Month Target Price $8.75

We have been covering CCNI for some time now, and we must admit, we seem to have a hard time nailing down the numbers one quarter to the next. After last quarter, we noted that we were “paring back some of our estimates just to try to get them more in line with the results over the past few quarters where revenue comps have been flat”. However, as it turned out, they reported revenues of $26.3 million which was just over $760,000 or about 3% higher than our revised estimate. The $26.3 million was about ½ way between the Q1 estimate we revised down, and the new number we revised down to.

Click Here for Report

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

Dec 26-18









(listing, quotes, news, research)







Aethlon Medical, Inc. (AEMD)





Alvopetro Energy, Ltd. (ALVOF)





Assure Holdings, Inc. (ARHH)





Antibe Therapeutics, Inc (ATBPF)





AzuerRx Biopharma, Inc. (AZRX)




Camino Minerals Corp. (CAMZF)




Canbiola, Inc. (CANB)




News, Inc. (CIIX)




Clean Coal Technologies, Inc (CCTC)




Command Center , Inc. (CCNI)





Endurance Exploration Group, Ltd (EXPL)





Ecom Products Group (EPGC)









Galaxy Gaming, Inc. (GLXZ)





Guangdong Land Holdings Limited (124) HK



Magnegas, Inc. (MNGA)





MOBI724 Global Solutions, Inc. (MOBIF)




New Jersey Mining Company (NJMC)




Petroshare Corp. (PRHR)





Summit Wireless Technologies, Inc.





Social Reality, Inc. (SRAX)





Zynex, Inc. (ZYXI)








December 21st, 2018

This week, we provide top-five ranked VE data for our Utilities Sector stocks, we also take a look at Altria Group $MO and provide a free download link for our stock report on the company. 

For Complete Report Click HERE


VALUATION WATCH: Overvalued stocks now make up 21.32% of our stocks assigned a valuation and 7.44% of those equities are calculated to be overvalued by 20% or more. Twelve sectors are calculated to be overvalued.  

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners


Black Swan Research Coverage and Subscription Service
Click Here>>


Event Calendar Updates

LD Micro   
December 4-6

Luxe Sunset | Bel-Air, CA
Click Here for Info

Awesome turnout at LD Micro. After the problems with fires etc this turned out terrific in spite of some inclement weather. Hats off to Chris and his team!!

See the lead feature Article by Dave Lavigne in the Black Swan Newsletter this month

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage


SMM Distribution Update

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6

SMM Instagram                      (followers)                             131         

Direct Email                                                                 345,000

Total                                                                             353,485


This post has not been tagged.

Share |
Permalink | Comments (0)
Community Search
Sign In